Truscreen Group (ASX:TRU) Other Current Receivables: A$0.33 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Truscreen Group Other Current Receivables?

Truscreen Group ASX:TRU +7.69% Other Current Receivables is A$0.33 Mil as of Mar. 2026. The stock has 4 warning signs investors should review.

Truscreen Group's Other Current Receivables for the quarter that ended in Mar. 2026 was A$0.33 Mil.

Truscreen Group's quarterly Other Current Receivables increased from Sep. 2024 (A$0.00 Mil) to Mar. 2025 (A$0.37 Mil) but then stayed the same from Mar. 2025 (A$0.37 Mil) to Mar. 2026 (A$0.33 Mil).

Truscreen Group's annual Other Current Receivables declined from Mar. 2024 (A$0.45 Mil) to Mar. 2025 (A$0.37 Mil) and declined from Mar. 2025 (A$0.37 Mil) to Mar. 2026 (A$0.33 Mil).

Truscreen Group Other Current Receivables Related Terms

Truscreen Group Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Truscreen Group's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Truscreen Group Other Current Receivables Chart

Truscreen Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.31 0.45 0.37 0.33

Truscreen Group Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.45 0.00 0.37 0.33

Truscreen Group Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of A$0.33 Mil mean?
Truscreen Group (ASX:TRU) has a Other Current Receivables of A$0.33 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Truscreen Group and its competitors.
Is Truscreen Group's Other Current Receivables too high?
Truscreen Group's current Other Current Receivables is A$0.33 Mil.
How does Truscreen Group's Other Current Receivables compare to ABT and SYK?
Truscreen Group's Other Current Receivables of A$0.33 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Truscreen Group and its competitors. Truscreen Group's current Other Current Receivables is A$0.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Truscreen Group stock overvalued right now?
Based on GuruFocus' analysis, Truscreen Group (ASX:TRU) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 40% above its estimated fair value. The current Other Current Receivables is A$0.33 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Truscreen Group (ASX:TRU), the current Other Current Receivables is A$0.33 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Truscreen Group Business Description

Other Exchanges TRU:New Zealand
Address C/- HLB Mann Judd Limited, 57 Symonds Street, Level 6, Equitable House, Grafton, Auckland, NZL, 1010
Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening device, which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.